Literature DB >> 24201778

Acquired immunity plays an important role in the development of murine experimental pancreatitis induced by alcohol and lipopolysaccharide.

Shinji Nakayama1, Akiyoshi Nishio, Masao Yamashina, Takashi Okazaki, Yutaku Sakaguchi, Katsunori Yoshida, Toshiro Fukui, Kazushige Uchida, Kazuichi Okazaki.   

Abstract

OBJECTIVE: Although chronic alcohol ingestion is the major cause of chronic pancreatitis, less than 10% of alcohol abusers develop this disease. To address this issue, we created a murine model of pancreatitis induced by alcohol and lipopolysaccharide (LPS) and analyzed its immune responses.
METHODS: C57BL/6 mice were administered 20% ethanol (AL) in their drinking water and then injected intraperitoneally with LPS twice weekly for 4 weeks. Severe combined immunodeficient mice were reconstituted with splenocytes, CD4 cells, or CD8 T cells isolated from wild-type mice and then treated similarly. The severity of pancreatitis was graded histologically, and serum cytokine levels were measured.
RESULTS: Ethanol alone did not cause pancreatitis. However, the administration of AL+LPS or LPS alone induced pancreatitis. The histological scores were higher in the mice treated with AL+LPS than in those treated with LPS. Serum levels of interleukin 1β, interferon-γ, and tumor necrosis factor α were elevated in the AL+LPS-treated mice. The severe combined immunodeficient mice developed pancreatitis only after their reconstitution with splenocytes, CD4 cells, or CD8 T cells.
CONCLUSIONS: Repeated stimulation of the innate immune system is necessary, but not sufficient, to cause pancreatitis. The participation of the acquired immune response is essential for the development of the disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24201778     DOI: 10.1097/MPA.0b013e3182a7c76b

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  7 in total

1.  Repeated Stimulation of Toll-Like Receptor 2 and Dectin-1 Induces Chronic Pancreatitis in Mice Through the Participation of Acquired Immunity.

Authors:  Masahiro Takeo; Akiyoshi Nishio; Masataka Masuda; Kazunori Aoi; Takashi Okazaki; Toshiro Fukui; Kazushige Uchida; Makoto Naganuma; Kazuichi Okazaki
Journal:  Dig Dis Sci       Date:  2021-08-23       Impact factor: 3.487

2.  The Reduction of Peripheral Blood CD4+ T Cell Indicates Persistent Organ Failure in Acute Pancreatitis.

Authors:  Zhiyong Yang; Yushun Zhang; Liming Dong; Chong Yang; Shanmiao Gou; Tao Yin; Heshui Wu; Chunyou Wang
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

3.  Hydroxyethyl starch resuscitation downregulate pro-inflammatory cytokines in the early phase of severe acute pancreatitis: A retrospective study.

Authors:  Qi-Jun Chen; Zhi-Yong Yang; Chun-You Wang; Li-Ming Dong; Yu-Shun Zhang; Chao Xie; Chang-Zhong Chen; Shi-Kai Zhu; Hong-Ji Yang; He-Shui Wu; Chong Yang
Journal:  Exp Ther Med       Date:  2016-09-23       Impact factor: 2.447

4.  Neutrophil to lymphocyte ratio predicts persistent organ failure and in-hospital mortality in an Asian Chinese population of acute pancreatitis.

Authors:  Yushun Zhang; Wei Wu; Liming Dong; Chong Yang; Ping Fan; Heshui Wu
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

5.  The Decrease of Peripheral Blood CD4+ T Cells Indicates Abdominal Compartment Syndrome in Severe Acute Pancreatitis.

Authors:  Yao Liu; Ling Wang; Zhifang Cai; Peng Zhao; Cijun Peng; Lijin Zhao; Chidan Wan
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

Review 6.  T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?

Authors:  Qi Zhou; Xufeng Tao; Shilin Xia; Fangyue Guo; Chen Pan; Hong Xiang; Dong Shang
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

Review 7.  Uniting Epidemiology and Experimental Disease Models for Alcohol-Related Pancreatic Disease.

Authors:  Veronica Wendy Setiawan; Kristine Monroe; Aurelia Lugea; Dhiraj Yadav; Stephen Pandol
Journal:  Alcohol Res       Date:  2017
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.